AJP - Regulatory, Integrative and Comparative Physiology, Vol 258, Issue 2 462-R468, Copyright © 1990 by American Physiological Society

ARTICLES

Effect of Ca2(+)-channel agonists and antagonists on skeletal muscle sugar transport

M. V. Westfall and M. M. Sayeed
Department of Physiology, Loyola University Stritch School of Medicine, Maywood, Illinois 60153.

The purpose of this study was to determine whether changes in cellular Ca2+ caused by Ca2(+)-channel modifiers affect skeletal muscle sugar transport. Rat soleus muscles were isolated, and sugar transport was measured monitoring efflux of 3-O-methylglucose (3-MG). Muscles were "loaded" with 3-O-[methyl-14C]methyl-D-glucose in Krebs-Ringer-bicarbonate (KRB) media and then sequentially washed in radioisotope-free KRB. Cellular Ca2+ was modified by adding a Ca2+ agonist (BAY K 8644) and/or Ca2+ antagonists (nifedipine, nitrendipine, diltiazem) to the "load" and "wash" media. Alterations in cellular Ca2+ were determined from soleus muscle 45Ca2+ uptake measurements. Addition of 0.25 microM BAY K 8644 enhanced insulin-mediated 3-MG transport and 1 microM nifedipine prevented the agonist effect. A high concentration of BAY K 8644 (6 microM) led to increased basal but attenuated insulin-mediated 3-MG transport. Nifedipine (4 microM) and diltiazem (20 microM) blocked the BAY K 8644-induced changes in basal and insulin-mediated 3-MG transport. Nifedipine (4 microM) also attenuated the stimulation of cellular Ca2+ uptake by 6 microM BAY K 8644. Nitrendipine was unable to reverse the changes in basal or insulin-mediated 3-MG transport caused by BAY K 8644. These results indicate that a low concentration of BAY K 8644 enhanced insulin-stimulated skeletal muscle sugar transport, whereas a high concentration of the agonist led to a diminished ability of insulin to stimulate sugar transport. The effects of the Ca2+ agonist were presumably mediated through modulation of cellular Ca2+ as these effects were blunted by the Ca2+ antagonists.

This article has been cited by other articles:

				J. T. Lanner, A. Katz, P. Tavi, M. E. Sandstrom, S.-J. Zhang, C. Wretman, S. James, J. Fauconnier, J. Lannergren, J. D. Bruton, et al. The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes, July 1, 2006; 55(7): 2077 - 2083. [Abstract] [Full Text] [PDF]

				T. D. Ardizzone, X.-H. Lu, and D. S. Dwyer Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists Am J Physiol Cell Physiol, August 1, 2002; 283(2): C579 - C586. [Abstract] [Full Text] [PDF]

				A. Kudoh, H. Katagai, and T. Takazawa Sevoflurane Increases Glucose Transport in Skeletal Muscle Cells Anesth. Analg., July 1, 2002; 95(1): 123 - 128. [Abstract] [Full Text] [PDF]

				A. Kudoh and A. Matsuki Halothane and Sevoflurane Decrease Norepinephrine-Stimulated Glucose Transport in Neonatal Cardiomyocyte Anesth. Analg., October 1, 2000; 91(5): 1151 - 1159. [Abstract] [Full Text] [PDF]